Liu Ziqin, Chen Xiaobo
Department of Endocrinology, Children's Hospital Capital Institute of Pediatrics, Beijing, China.
Transl Pediatr. 2021 Jul;10(7):1932-1939. doi: 10.21037/tp-21-152.
rogressive pseudorheumatoid dysplasia (PPRD) is a rare autosomal-recessive, noninflammatory arthropathy. Several cases have been reported worldwide; however, diagnosis remains challenging. Three unrelated children with PPRD were retrospectively studied. All three patients in this study were initially misdiagnosed. The misdiagnoses included juvenile rheumatoid arthritis, myodystrophy and idiopathic short stature. The time from the onset of symptoms to a definitive diagnosis was 3 to 8 years. Clinical signs and radiological phenotypes were analyzed carefully, and they were all consistent with the characteristics of PPRD and noninflammatory polyarticular enlargement. The small joints of both the hands and lower limbs are the most affected. The imaging findings of the patients were flat vertebrae with beak- or bullet-like changes in front of the cone and peripheral metaphysis widening. DNA samples obtained from the family were sequenced to identify the causal gene using whole-exome sequencing (WES). Four Wnt1-inducible signaling pathway protein 3 () mutations were verified. c.271delC was not reported previously. The other three mutations, namely, c.136C>T (p. Gln46*), c.667T>G (p. Cys223Gly) and c.589+2T>C, were previously identified. All three patients had a long journey to diagnosis. Early genetic diagnosis can help prevent unnecessary treatments and procedures in patients. Growth hormone is not a good choice for treatment.
进行性假类风湿性发育不良(PPRD)是一种罕见的常染色体隐性非炎性关节病。全球已报道了数例;然而,诊断仍然具有挑战性。对3例无关的PPRD患儿进行了回顾性研究。本研究中的3例患者最初均被误诊。误诊包括幼年类风湿关节炎、肌营养不良和特发性身材矮小。从症状出现到明确诊断的时间为3至8年。仔细分析了临床体征和放射学表型,它们均与PPRD及非炎性多关节肿大的特征相符。双手和下肢的小关节受累最为严重。患者的影像学表现为椎体扁平,椎体前方呈喙状或子弹样改变,干骺端外周增宽。从家族中获取DNA样本,采用全外显子测序(WES)来鉴定致病基因。验证了4个Wnt1诱导信号通路蛋白3()突变。c.271delC此前未见报道。其他3个突变,即c.136C>T(p.Gln46*)、c.667T>G(p.Cys223Gly)和c.589+2T>C,此前已被鉴定。这3例患者均经历了漫长的诊断过程。早期基因诊断有助于避免患者接受不必要的治疗和检查。生长激素不是治疗的理想选择。